Bone Marrow Pathology Predicts Mortality in Chronic Hemodialysis Patients

Table 1

Baseline data of the patients stratified according to survival status ().

Variable	Total ()	Survivors ()	Nonsurvivors ()	value
Age (years)	63.5 17.2	61.7 18.06	66.4 15.6	0.237
Female gender, (%)	36 (46.2%)	21 (43.8%)	27 (56.3%)	0.645
Hypertension, (%)	58 (74.4%)	38 (79.2%)	20 (66.7%)	0.288
Diabetes mellitus, (%)	30 (38.5)	16 (33.3%)	14 (46.7%)	0.339
Smoking habit, (%)	19 (24.4%)	12 (25.0%)	7 (23.3%)	1.000
Alcohol consumption, (%)	11 (14.1%)	5 (10.4%)	6 (20.0%)	0.319
Antihypertensive agents, (%)	58 (74.4%)	36 (75.0%)	22 (73.3%)	1.000
Lipid-lowering agents, (%)	4 (5.1%)	3 (6.2%)	1 (3.3%)	1.000
Iron, (%)	59 (75.6%)	38 (79.2%)	21 (70.0%)	0.421
Erythropoietin, (%)	48 (61.5%)	32 (66.7%)	16 (53.3%)	0.339
Duration of followup (months)	19.3 26.8	22.4 30.0	14.3 22.4	0.196
	2.1 0.8	2.09 0.6	2.21 0.4	0.120